{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:09:45Z","timestamp":1792800585132,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute for Communicable Diseases","id":[{"id":"https:\/\/ror.org\/007wwmx82","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","award":["Research Incentive"],"award-info":[{"award-number":["Research Incentive"]}],"id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12936-019-2911-y","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T05:03:17Z","timestamp":1566450197000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18\u00a0years of artemisinin-based combination therapy use in Mpumalanga Province, South Africa (2001\u20132018)"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0728-3093","authenticated-orcid":false,"given":"Jaishree","family":"Raman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank M.","family":"Kagoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Mabuza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Malatje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Frean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen I.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,22]]},"reference":[{"key":"2911_CR1","unstructured":"WHO. World malaria report, 2018. Geneva: World Health Organization; 2018. \n                    http:\/\/www.who.int\/malaria\/publications\/world-malaria-report-2018\/report\/en\/\n                    \n                  . Accessed 27 June 2019."},{"key":"2911_CR2","unstructured":"WHO. Global report on antimalarial drug efficacy and drug resistance, 2000\u20132010. Geneva: World Health Organization; 2010. \n                    http:\/\/www.who.int\/malaria\/publications\/atoz\/9789241500470\/en\/\n                    \n                  . Accessed 27 June 2019."},{"key":"2911_CR3","unstructured":"WHO. Guidelines for the treatment of malaria. 3rd edn. Geneva: World Health Organization; 2015. \n                    http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/162441\/9789241549127_eng.pdf;jsessionid=6A8BD95D41D35B441DB453E032AE1905?sequence=1\n                    \n                  . Accessed 27 June 2019."},{"key":"2911_CR4","first-page":"358","volume":"91","author":"L Baker","year":"2001","unstructured":"Baker L, Barnes K. New antimalarial treatment in KwaZulu-Natal. S Afr Med J. 2001;91:358\u20139.","journal-title":"S Afr Med J"},{"key":"2911_CR5","doi-asserted-by":"publisher","first-page":"793","DOI":"10.7196\/SAMJ.7443","volume":"103","author":"IS Ukpe","year":"2013","unstructured":"Ukpe IS, Moonasar D, Raman J, Barnes KI, Baker L, Blumberg L. Case management of malaria: treatment and chemoprophylaxis. S Afr Med J. 2013;103:793\u20138.","journal-title":"S Afr Med J"},{"key":"2911_CR6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.4269\/ajtmh.2008.78.455","volume":"78","author":"AA Djimde","year":"2008","unstructured":"Djimde AA, Fofana B, Sagara I, Sidibe B, Toure S, Dembele D, et al. Efficacy, safety and selection of molecular markers of drug resistance by two ACTs in Mali. Am J Trop Med Hyg. 2008;78:455\u201361.","journal-title":"Am J Trop Med Hyg"},{"key":"2911_CR7","doi-asserted-by":"publisher","first-page":"788","DOI":"10.4269\/ajtmh.2010.09-0401","volume":"82","author":"J Raman","year":"2010","unstructured":"Raman J, Little F, Roper C, Kleinschmidt I, Cassim Y, Maharaj R, et al. Five years of large-scale dhfr and dhps mutation surveillance following the phased implementation of artesunate plus sulfadoxine-pyrimethamine in Maputo Province, southern Mozambique. Am J Trop Med Hyg. 2010;82:788\u201394.","journal-title":"Am J Trop Med Hyg"},{"key":"2911_CR8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455\u201367.","journal-title":"N Engl J Med"},{"key":"2911_CR9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S1473-3099(15)70032-0","volume":"15","author":"KM Tun","year":"2015","unstructured":"Tun KM, Imwong M, Lwin KM, Win AA, Hlaing TM, Hlaing T, et al. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. Lancet Infect Dis. 2015;15:415\u201321.","journal-title":"Lancet Infect Dis."},{"key":"2911_CR10","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411\u201323.","journal-title":"N Engl J Med"},{"key":"2911_CR11","unstructured":"WHO. Artemisinin resistance and artemisinin-based combination therapy efficacy. Geneva: World Health Organization; 2018. Available: \n                    http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/274362\/WHO-CDS-GMP-2018.18-eng.pdf?ua=1\n                    \n                  . Accessed 27 June 2019."},{"key":"2911_CR12","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1056\/NEJMc1713777","volume":"379","author":"S Das","year":"2018","unstructured":"Das S, Saha B, Hati AK, Roy S. Evidence of artemisinin-resistant Plasmodium falciparum malaria in eastern India. N Engl J Med. 2018;379:1962\u20134.","journal-title":"N Engl J Med"},{"key":"2911_CR13","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMc1612765","volume":"376","author":"F Lu","year":"2017","unstructured":"Lu F, Culleton R, Zhang M, Ramaprasad A, von Seidlein L, Zhou H, et al. Emergence of indigenous artemisinin-resistant Plasmodium falciparum in Africa. N Engl J Med. 2017;376:991\u20133.","journal-title":"N Engl J Med"},{"key":"2911_CR14","first-page":"e02382","volume":"61","author":"CJ Sutherland","year":"2017","unstructured":"Sutherland CJ, Lansdell P, Sanders M, Muwanguzi J, van Schalkwyk DA, Kaur H, et al. pfk13-independent treatment failure in four imported cases of Plasmodium falciparum malaria treated with artemether-lumefantrine in the United Kingdom. Antimicrob Agents Chemother. 2017;61:e02382.","journal-title":"Antimicrob Agents Chemother"},{"key":"2911_CR15","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3201\/eid2404.170141","volume":"24","author":"M Ikeda","year":"2018","unstructured":"Ikeda M, Kaneko M, Tachibane S-I, Balikagala B, Sakurai-Yatsushiro M, Yatsushiro S, et al. Artemisinin-resistant Plasmodium falciparum with high survival rates, Uganda, 2014\u20132016. Emerg Infect Dis. 2018;24:718\u201326.","journal-title":"Emerg Infect Dis"},{"key":"2911_CR16","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/infdis\/jiu467","volume":"211","author":"SA Taylor","year":"2014","unstructured":"Taylor SA, Parobek CM, DeConti DK, Kayentao K, Coulibaly SO, Greenwood BM, et al. Absence of putative artemisinin resistance mutations among Plasmodium falciparum in sub-Saharan Africa: a molecular epidemiologic study. J Infect Dis. 2014;211:680\u20138.","journal-title":"J Infect Dis"},{"key":"2911_CR17","unstructured":"Southern African Development Community, SADC Malaria Report, 2017; 2017."},{"key":"2911_CR18","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1111\/j.1365-3156.2004.01341.x","volume":"9","author":"MH Craig","year":"2004","unstructured":"Craig MH, Kleinschmidt I, le Sueur D, Sharp BL. Exploring 30\u00a0years of malaria case data in KwaZulu-Natal, South Africa: Part II. The impact of non-climatic factors. Trop Med Int Health. 2004;9:1258\u201366.","journal-title":"Trop Med Int Health."},{"key":"2911_CR19","unstructured":"WHO. Methods for surveillance of antimalarial drug efficacy. Geneva: World Health Organization; 2009. \n                    http:\/\/www.who.int\/malaria\/publications\/atoz\/9789241597531\/en\/\n                    \n                  . Accessed 27 June 2019."},{"key":"2911_CR20","doi-asserted-by":"publisher","first-page":"e25992","DOI":"10.1371\/journal.pone.0025992","volume":"6","author":"J Raman","year":"2011","unstructured":"Raman J, Mauff K, Muiaga P, Mussa A, Maharaj R, Barnes KI. Five years of antimalarial resistance marker surveillance in Gaza Province, Mozambique following artemisinin-based combination therapy roll out. PLoS ONE. 2011;6:e25992.","journal-title":"PLoS ONE"},{"key":"2911_CR21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/aje\/kwf030","volume":"156","author":"F Mendez","year":"2002","unstructured":"Mendez F, Munoz A, Carrasquilla G, Jurado D, Arevalo-Herrera M, Cortese JF, et al. Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria. Am J Epidemiol. 2002;156:230\u20138.","journal-title":"Am J Epidemiol"},{"key":"2911_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.actatropica.2005.06.015","volume":"95","author":"CT Happi","year":"2005","unstructured":"Happi CT, Gbotosho GO, Folarin OA, Akinboye DO, Yusef BO, Ebong OO, et al. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients in Nigeria. Acta Trop. 2005;95:183\u201393.","journal-title":"Acta Trop"},{"key":"2911_CR23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1056\/NEJM200101253440403","volume":"344","author":"A Djimde","year":"2001","unstructured":"Djimde A, Ogobara K, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, et al. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med. 2001;344:257\u201363.","journal-title":"N Engl J Med"},{"key":"2911_CR24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariery","year":"2014","unstructured":"Ariery F, Witkowski B, Amaratunga C, Beghain J, Langlois A-C, Khim N, et al. A molecular marker for artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50\u201367.","journal-title":"Nature"},{"key":"2911_CR25","unstructured":"South Africa National Department of Health. National Malaria Elimination Strategy 2011\u20132018. Technical report, South Africa National Department of Health, Pretoria; 2011."},{"key":"2911_CR26","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1186\/1475-2875-11-423","volume":"11","author":"R Maharaj","year":"2012","unstructured":"Maharaj R, Morris N, Seocharan I, Kruger P, Moonasar D, Mabuza A, et al. The feasibility of malaria elimination in South Africa. Malar J. 2012;11:423.","journal-title":"Malar J."},{"key":"2911_CR27","unstructured":"South Africa National Department of Health. National malaria statistics. Technical report. Pretoria: South Africa National Department of Health; 2013."},{"key":"2911_CR28","doi-asserted-by":"publisher","first-page":"784","DOI":"10.7196\/SAMJ.7447","volume":"103","author":"BD Brooke","year":"2013","unstructured":"Brooke BD, Koekemoer LL, Kruger P, Urbach J, Misiani E, Coetzee M. Malaria vector control in South Africa. S Afr Med J. 2013;103:784\u20138.","journal-title":"S Afr Med J"},{"key":"2911_CR29","unstructured":"South African National Department of Health. Guidelines for the treatment of malaria in South Africa: 2018. Technical report, South Africa National Department of Health; 2018."},{"key":"2911_CR30","unstructured":"Statistics South Africa. South African census 2011. Technical report. Pretoria: Statistics South Africa; 2012."},{"key":"2911_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1475-2875-11-19","volume":"11","author":"L Ngomane","year":"2012","unstructured":"Ngomane L, de Jager C. Changes in malaria morbidity and mortality in Mpumalanga Province, South Africa (2001\u20132009): a retrospective study. Malar J. 2012;11:19.","journal-title":"Malar J."},{"key":"2911_CR32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/1475-2875-13-297","volume":"13","author":"SP Silal","year":"2014","unstructured":"Silal SP, Little F, Barnes KI, White LJ. Towards malaria elimination in Mpumalanga, South Africa: a population-level mathematical modelling approach. Malar J. 2014;13:297.","journal-title":"Malar J."},{"key":"2911_CR33","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/S0035-9203(99)90082-2","volume":"93","author":"JM Govere","year":"1999","unstructured":"Govere JM, La Grange JJ, Durrheim DN, Freese JA, Sharp BL, Mabuza A, et al. Sulfadoxine-pyrimethamine effectiveness against Plasmodium falciparum malaria in Mpumalanga Province, South Africa. Trans R Soc Trop Med. 1999;93:644.","journal-title":"Trans R Soc Trop Med."},{"key":"2911_CR34","first-page":"394","volume":"84","author":"HE Deacon","year":"1994","unstructured":"Deacon HE, Freese JA, Sharp BL. Drug-resistant Plasmodium falciparum malaria in the eastern Transvaal. S Afr Med J. 1994;84:394\u20135.","journal-title":"S Afr Med J"},{"key":"2911_CR35","first-page":"346","volume":"95","author":"A Mabuza","year":"2005","unstructured":"Mabuza A, Govere J, Grange K, Mngomezulu N, Allen E, Zitha A, et al. Therapeutic efficacy of sulfadoxine-pyrimethamine for Plasmodium falciparum malaria: a study 5\u00a0years after implementation of combination therapy in Mpumalanga. S Afr Med J. 2005;95:346\u20139.","journal-title":"S Afr Med J"},{"key":"2911_CR36","doi-asserted-by":"publisher","first-page":"e330","DOI":"10.1371\/journal.pmed.0020330","volume":"11","author":"KI Barnes","year":"2005","unstructured":"Barnes KI, Durrheim DN, Little F, Jackson A, Mehta U, Allen E, et al. Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PLoS Med. 2005;11:e330.","journal-title":"PLoS Med."},{"key":"2911_CR37","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0169-4758(93)90131-X","volume":"9","author":"J Wooden","year":"1993","unstructured":"Wooden J, Keyes S, Sibley CH. PCR and strain identification in Plasmodium falciparum. Parasitol Today. 1993;9:303\u20135.","journal-title":"Parasitol Today."},{"key":"2911_CR38","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1128\/JCM.43.5.2435-2440.2005","volume":"43","author":"KA Mangold","year":"2005","unstructured":"Mangold KA, Manson RU, Koay ESC, Stephens L, Regner M, Thomson RB, et al. Real-time PCR for detection and identification of Plasmodium spp. J Clin Microbiol. 2005;43:2435\u201340.","journal-title":"J Clin Microbiol"},{"key":"2911_CR39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1179\/000349803125002977","volume":"97","author":"D Padley","year":"2003","unstructured":"Padley D, Moody AH, Chiodini PL, Saldanha J. Use of a rapid, single-round multiplex PCR to detect malarial parasites and identify the species present. Ann Trop Med Parasitol. 2003;97:131\u20137.","journal-title":"Ann Trop Med Parasitol"},{"key":"2911_CR40","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1086\/514159","volume":"176","author":"CV Plowe","year":"1997","unstructured":"Plowe CV, Cortese JF, Djimde A, Nwanyanwu OC, Watkins WM, Winstanley PA, et al. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J Infect Dis. 1997;176:1590\u20136.","journal-title":"J Infect Dis"},{"key":"2911_CR41","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/jac\/dkm104","volume":"59","author":"CJ Sutherland","year":"2007","unstructured":"Sutherland CJ, Haustein T, Gadalla N, Amstrong M, Doherty JF, Choidini PL. Chloroquine-resistant Plasmodium falciparum infections among UK travellers returning with malaria after chloroquine prophylaxis. Antimicrob Agents Chemother. 2007;59:1197\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"2911_CR42","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","volume":"364","author":"RN Price","year":"2004","unstructured":"Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet. 2004;364:438\u201347.","journal-title":"Lancet"},{"key":"2911_CR43","doi-asserted-by":"publisher","first-page":"e0136099","DOI":"10.1371\/journal.pone.0136099","volume":"10","author":"E Talundzic","year":"2015","unstructured":"Talundzic E, Chenet SM, Goldman IF, Patel DS, Nelson JA, Plucinski MM, et al. Genetic analysis and species specific amplification of the artemisinin resistance-associated kelch propeller domain in P. falciparum and P. vivax. PLoS ONE. 2015;10:e0136099.","journal-title":"PLoS ONE."},{"key":"2911_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-018-1207-3","volume":"17","author":"WWARN k13 Genotype-Phenotype Study Group","year":"2019","unstructured":"WWARN k13 Genotype-Phenotype Study Group. Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments\u2014a WWARN individual patient data meta-analysis. BMC Med. 2019;17:1.","journal-title":"BMC Med."},{"key":"2911_CR45","unstructured":"GADM. Maps and data; 2018. \n                    https:\/\/gadm.org\/index.html\n                    \n                  . Accessed 11 Feb 2019."},{"key":"2911_CR46","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/1467-8306.00310","volume":"92","author":"CA Brewer","year":"2002","unstructured":"Brewer CA, Pickle L. Evaluation of methods for classifying epidemiological data on Choropleth maps in series. Ann Assoc Am Geogr. 2002;92:662\u201381.","journal-title":"Ann Assoc Am Geogr"},{"key":"2911_CR47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1179\/000870403235002042","volume":"40","author":"M Harrower","year":"2003","unstructured":"Harrower M, Brewer C. A ColorBrewer.org: an online tool for selecting colour schemes for maps. Cartographic J. 2003;40:27\u201337.","journal-title":"Cartographic J."},{"key":"2911_CR48","doi-asserted-by":"publisher","first-page":"e000999","DOI":"10.1136\/bmjgh-2018-000999","volume":"3","author":"LC Okell","year":"2018","unstructured":"Okell LC, Reiter LM, Ebbe LS, Baraka V, Bisanzio D, Watson OJ, et al. Emerging implications of policies on malaria treatment: genetic changes in the Pfmdr-1 gene affecting susceptibility to artemether-lumefantrine and artesunate-amodiaquine in Africa. BMJ Glob Health. 2018;3:e000999.","journal-title":"BMJ Glob Health."},{"key":"2911_CR49","doi-asserted-by":"publisher","first-page":"833","DOI":"10.4269\/ajtmh.14-0031","volume":"91","author":"M Venkatesan","year":"2014","unstructured":"Venkatesan M, Gadalla NB, Stepniewska K, Dahal P, Nsanzabana C, Moriera C, et al. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine. Am J Trop Med Hyg. 2014;91:833\u201343.","journal-title":"Am J Trop Med Hyg."},{"key":"2911_CR50","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1093\/infdis\/jis747","volume":"2017","author":"M Malmberg","year":"2013","unstructured":"Malmberg M, Ferreira PE, Tarning J, Ursing J, Ngasala B, Bjorkman A, et al. Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms. J Infect Dis. 2013;2017:842\u20137.","journal-title":"J Infect Dis."},{"key":"2911_CR51","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1086\/375419","volume":"187","author":"JG Kublin","year":"2003","unstructured":"Kublin JG, Cortese JF, Njunju EM, Makadam RA, Wirima JJ, Kazembe PN, et al. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after the cessation of chloroquine use in Malawi. J Infect Dis. 2003;187:1870\u20135.","journal-title":"J Infect Dis"},{"key":"2911_CR52","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12936-018-2290-9","volume":"17","author":"E Davlantes","year":"2018","unstructured":"Davlantes E, Dimbu PR, Ferreira CM, Joao MF, Pode D, Felix J, et al. Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquinne, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017. Malar J. 2018;17:144.","journal-title":"Malar J."},{"key":"2911_CR53","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12936-017-1712-4","volume":"16","author":"MM Plucinski","year":"2017","unstructured":"Plucinski MM, Dimbu PR, Macaia AP, Ferreira CM, Samutondo C, Quivinja J, et al. Efficacy of arthmether-lumefantrine, artesunate-amodiaquinne, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015. Malar J. 2017;16:62.","journal-title":"Malar J."},{"key":"2911_CR54","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12936-019-2841-8","volume":"18","author":"J Raman","year":"2019","unstructured":"Raman J, Allen E, Workman L, Mabuza A, Swanepoel H, Malatje G, et al. Safety and tolerability of single low-dose primaquine in a low-intensity transmission area in South Africa: an open-label, randomized controlled trial. Malar J. 2019;18:209.","journal-title":"Malar J."},{"key":"2911_CR55","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1186\/1475-2875-11-434","volume":"11","author":"CH Vaughan-Williams","year":"2012","unstructured":"Vaughan-Williams CH, Raman J, Raswiswi E, Immelman E, Reichel H, Gates K, et al. Assessment of the therapeutic efficacy of artemether\u2013lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in northern KwaZulu-Natal: an observational cohort study. Malar J. 2012;11:434.","journal-title":"Malar J."},{"key":"2911_CR56","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s12936-015-0860-7","volume":"14","author":"E Artimovich","year":"2015","unstructured":"Artimovich E, Kapito-Tembo A, Pensulo P, Nyirenda O, Brown S, Joshi S, et al. The effects of local variations in malaria transmission on the prevalence of sulfadoxine-pyrimethamine resistant haplotypes and selective sweep characteristics in Malawi. Malar J. 2015;14:387.","journal-title":"Malar J."},{"key":"2911_CR57","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1172\/JCI21682","volume":"113","author":"NJ White","year":"2004","unstructured":"White NJ. Antimalarial drug resistance. J Clin Invest. 2004;113:1084\u201392.","journal-title":"J Clin Invest."},{"key":"2911_CR58","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1475-2875-10-6","volume":"10","author":"DS Ishengoma","year":"2011","unstructured":"Ishengoma DS, Lwitiho S, Madebe RA, Nyagonde N, Persson O, Vestergaard LS, et al. Using rapid diagnostic tests as source of malaria parasite DNA for molecular analyses in the era of declining malaria prevalence. Malar J. 2011;10:6.","journal-title":"Malar J."},{"key":"2911_CR59","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1186\/s12936-015-0861-6","volume":"14","author":"N Papa Mze","year":"2015","unstructured":"Papa Mze N, Ndiaye YD, Diedhiou CK, Rahamatou D, Dieye B, Daniels RF, et al. RDTs as a source of DNA to study Plasmodium falciparum drug resistance in isolates from Senegal and the Comoros Islands. Malar J. 2015;14:373.","journal-title":"Malar J."},{"key":"2911_CR60","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.4269\/ajtmh.17-0021","volume":"97","author":"M Ndiaye","year":"2017","unstructured":"Ndiaye M, Sow D, Nag S, Sylla K, Tine RC, Ndiaye JL, et al. Country-wide surveillance of molecular markers of antimalarial drug resistance in Senegal by use of positive malaria rapid diagnostic tests. Am J Trop Med. 2017;97:1593\u20136.","journal-title":"Am J Trop Med."},{"key":"2911_CR61","unstructured":"World Health Organization. Malaria surveillance, monitoring and evaluation: a reference manual; 2018. \n                    https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/272284\/9789241565578-eng.pdf?ua=1\n                    \n                  . Accessed 27 June 2019."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-019-2911-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12936-019-2911-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-019-2911-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T19:08:37Z","timestamp":1597950517000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-019-2911-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,22]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2911"],"URL":"https:\/\/doi.org\/10.1186\/s12936-019-2911-y","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,22]]},"assertion":[{"value":"10 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval for this study was obtained from the Mpumalanga Provincial Department of Health (MP_2015RP53_229), and the University of Witwatersrand Human Research Ethics Committee: Medical (M160229). It also met the criteria for studies of routinely-collected data of the Ethics Review Board of M\u00e9decins Sans Fronti\u00e8res.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Permission for publication was received from the Manager of the Mpumalanga Provincial Malaria Elimination Programme.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"280"}}